Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours
S.A. Sohaib(Royal Marsden NHS Foundation Trust), Robert Huddart(Institute of Cancer Research), Yolanda Barbáchano(Royal Marsden NHS Foundation Trust), D.P. Dearnaley(Royal Marsden NHS Foundation Trust), J. Parikh(Royal Marsden NHS Foundation Trust), A. Horwich(Institute of Cancer Research), Janet E. Husband(Royal Marsden NHS Foundation Trust), Dow‐Mu Koh(Royal Marsden NHS Foundation Trust)
Cited by 97
Related Papers
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers
|UCL Discovery (University College London)|1997|1k
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
|The Lancet Oncology|2013|728
The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20
|European Journal of Cancer|2005|576
Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer
|Journal of Clinical Oncology|2003|548